OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

GALENICA N/  CH0360674466  /

SIX Swiss Exchange
2024-04-16  4:52:02 PM Chg. -0.55 Volume Bid4:55:08 PM Ask4:55:08 PM Market Capitalization Dividend Y. P/E Ratio
70.05CHF -0.78% 41,156
Turnover: 2.89 mill.		 69.95Bid Size: 353 70.10Ask Size: 133 3.51 bill.CHF 3.14% 12.26
GlobeNewswire 2023-09-18 AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
GlobeNewswire 2021-11-17 Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021
GlobeNewswire 2021-08-19 Biofrontera reports financial results for the six months ended June 30, 2021
GlobeNewswire 2021-07-06 Biofrontera reports preliminary revenue for the month of June 2021
GlobeNewswire 2021-04-12 Biofrontera reports results for the 2020 financial year
GlobeNewswire 2020-12-07 Biofrontera enters into a license and supply agreement with Galenica AB for the marketing of Ameluz®...
GlobeNewswire 2020-09-10 Opthea Appoints US-Based Non-Executive Director
GlobeNewswire 2020-05-21 Atreca Announces Appointment of Kristine M. Ball to its Board of Directors
GlobeNewswire 2019-07-11 Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer...
GlobeNewswire 2019-06-18 Menlo Therapeutics Announces Addition of Ronald A. Krasnow as General Counsel and Chief Compliance O...
GlobeNewswire 2018-08-28 VIFOR PHARMA ISSUES INAUGURAL CHF 465 MILLION BOND
GlobeNewswire 2018-06-25 NodThera secures £28 million ($40 million) Series A Financing
GlobeNewswire 2018-05-23 Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensin...
GlobeNewswire 2018-05-23 VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE...
GlobeNewswire 2018-05-15 90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING
GlobeNewswire 2018-05-15 90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING
GlobeNewswire 2018-05-08 Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa®...
GlobeNewswire 2018-05-08 US FDA APPROVES USE OF VELTASSA® WITH OR WITHOUT FOOD
GlobeNewswire 2018-04-16 Relypsa Funds Three Innovative Research Projects on Hyperkalemia and Associated Disorders
GlobeNewswire 2018-04-11 Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at t...
GlobeNewswire 2018-03-29 VIFOR PHARMA TO PROPOSE JACQUES THEURILLAT AS BOARD MEMBER
GlobeNewswire 2018-03-27 VIFOR PHARMA CONCLUDES LICENSING AGREEMENT WITH ZERIA TO MARKET VELTASSA® IN JAPAN
GlobeNewswire 2018-03-15 VIFOR PHARMA GROUP REPORTS STRONG 2017 RESULTS, EXCEEDING RAISED GUIDANCE
GlobeNewswire 2018-02-08 VIFOR PHARMA FERROPORTIN INHIBITOR ENTERS PHASE-I CLINICAL TRIAL
GlobeNewswire 2018-01-04 Avacopan Conditional Marketing Authorization Application Accepted for Regulatory Review by European ...